CCN4 and lung carcinoma: Thus, apoptotic cancer cell therapies targeting CAFs or cell-free therapies, such as treatment with CM from CAFs exposed to apoptotic cancer cells and CM components such as WISP-1, could be effective therapeutic approaches to inhibit lung cancer progression and metastasis.